Obstetric Pharmacology Research Units (U10)

Post Date

December 16th 2008

Application Due Date

March 30th 2009

Funding Opportunity Number

RFA-HD-09-002

CFDA Number(s)

93.865

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health
Income Security and Social Services

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $5000000

• Award Range:

  $None - $650000

Grant Description

Purpose. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites applications to participate in the Obstetric Pharmacology Research Units (OPRU) Network to serve as a resource for performance of pharmacologic studies of drug disposition and effect during normal and abnormal pregnancies. Within the Network, the OPRUs will: (1) conduct multi-site cooperative clinical studies of therapeutic modalities used during pregnancy; (2) conduct studies of fetal, placental and maternal pharmacology; (3) conduct studies on the effect of pregnancy on drug metabolizing enzymes, transporters and effectors, including interactions with pharmacogenetics/pharmacogenomics; (4) facilitate the collection and utilization of clinical materials for basic research studies; and (5) perform studies of placental metabolism and transfer of drugs; (6) enhance the exchange of information between basic scientists and obstetricians and among various specialists involved in treating pregnant women; (7) promote collaborations in interdisciplinary translational research. The Network will also serve as a resource for the training of health professionals, including pre- and post-doctoral fellows and PharmDs, in obstetric pharmacology, pharmacogenomics and clinical trials in pregnant women.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-09-002.html